Estimaciones de analistas de Wall Street para BeyondSpring Inc. (BYSI): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-17 | $-0.58 | ||
| 2026-11-12 | $-0.54 | ||
| 2026-08-14 | $-0.02 | $-0.54 | +96.3% |
| 2026-05-13 | $-0.05 | $-0.54 | +90.7% |
| 2026-03-25 | $-0.05 | $-0.54 | +90.3% |
| 2025-11-12 | $-0.05 | ||
| 2025-08-13 | $-0.04 | ||
| 2025-05-12 | $-0.06 |
Ratios de valoración
| Precio / Valor contable | -0.82 |
| EV / EBITDA | -2.91 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $180000 | $1.4M | $1.4M | 0 | 0 | 0 |
| Coste de Ventas | $18000 | $32000 | $48000 | $77000 | 0 | 0 | 0 | $302000 | 0 | $87000 |
| Beneficio Bruto | -$18000 | -$32000 | -$48000 | -$77000 | $180000 | $1.4M | $1.4M | -$302000 | 0 | -$87000 |
| I+D | $10.4M | $88.9M | $51.6M | $31.3M | $41.8M | $36.9M | $25.6M | $7.3M | $2.6M | $4.4M |
| Generales y Administrativos | $1.9M | $9.1M | $5.9M | $8.9M | $22.6M | $30.7M | $13.0M | $7.5M | $6.1M | $4.6M |
| Gastos Operativos | $12.4M | $98.0M | $57.5M | $40.2M | $64.4M | $67.6M | $38.6M | $14.8M | $8.8M | $8.9M |
| Beneficio Operativo | -$12.4M | -$98.0M | -$57.5M | -$40.3M | -$64.2M | -$66.2M | -$37.2M | -$15.1M | -$8.8M | -$8.9M |
| EBITDA | -$12.3M | -$97.9M | -$57.5M | -$40.0M | -$63.7M | -$64.5M | -$35.0M | -$13.6M | -$8.5M | -$8.5M |
| Gastos por Intereses | $177000 | 0 | 0 | $206000 | $85000 | $87000 | $17000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$12.5M | -$96.4M | -$57.5M | -$40.3M | -$63.8M | -$64.6M | -$36.1M | -$13.9M | -$8.8M | -$8.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $3.6M | $163000 | $92000 | $96000 | $90000 |
| Beneficio Neto | -$12.0M | -$91.8M | -$54.9M | -$38.1M | -$61.0M | -$64.2M | -$33.3M | -$21.0M | -$11.1M | -$8.0M |
| BPA | $-0.75 | $-4.40 | $-2.42 | $-1.55 | $-2.04 | $-1.64 | $-0.85 | $-0.54 | $-0.28 | $-0.20 |
| BPA Diluido | $-0.71 | $-4.40 | $-2.42 | $-1.55 | $-2.04 | $-1.64 | $-0.85 | $-0.54 | $-0.28 | $-0.20 |
| Acciones en Circulación (Diluidas) | $16.9M | $20.9M | $22.7M | $24.6M | $30.0M | $39.0M | $39.1M | $39.0M | $39.7M | $40.4M |
Precio
| Precio | $0.71 |
| Capitalización | $29M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ALXO · ATYR · BMEA · CAMP · DTIL · GUTS · HYFT
Explorar sector: Healthcare · Biotechnology
Más secciones de BYSI: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones